Greenwich LifeSciences, Inc.
GLSI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001799788
In the last 90 days, Greenwich LifeSciences, Inc. insiders filed 3 open-market purchases and 0 sales; 57 institutions reported holding it in 13F filings for Q2 2026, worth $39.6M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Greenwich LifeSciences, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 51 | 51 | 0 |
| Shares | 1.23M | 1.21M | −17.5K (−1.4%) |
| Value | $11.2M | $12.1M | +$909.3K (+8.1%) |
New holders (5)
Institutions that held Greenwich LifeSciences, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Deutsche Bank AG | 21,502 | $213.9K | 0.00% |
| SRS Capital Advisors, Inc. | 123 | $1.22K | 0.00% |
| Optiver Holding B.V. | 96 | $955 | 0.00% |
| The PNC Financial Services Group, Inc. | 29 | $289 | 0.00% |
| Sunbelt Securities, Inc. | 5 | $50 | 0.00% |
Sold out (5)
Institutions that held Greenwich LifeSciences, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| HighTower Advisors, LLC | 16,967 | $153.9K |
| Raymond James Financial Inc | 718 | $6.51K |
| Skopos Labs, Inc. | 244 | $2.21K |
| Federation des caisses Desjardins du Quebec | 100 | $907 |
| Jones Financial Companies LLLP | 10 | $90 |